• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于患者的质量控制技术入门。

A primer on patient-based quality control techniques.

作者信息

Badrick Tony, Cervinski Mark, Loh Tze Ping

机构信息

RCPA Quality Assurance Programs, Sydney, NSW, Australia.

Dartmouth-Hitchcock Medical Center, New Hampshire, USA.

出版信息

Clin Biochem. 2019 Feb;64:1-5. doi: 10.1016/j.clinbiochem.2018.12.004. Epub 2018 Dec 11.

DOI:10.1016/j.clinbiochem.2018.12.004
PMID:30550876
Abstract

BACKGROUND

Patient-based Quality Control techniques have been described for more than fifty years and have been widely used routinely in hematology for forty. However, because of practical issues they have not been widely utilised in clinical chemistry laboratories. But recently because of the availability of middleware and a greater appreciation of the benefits of these processes there has been a willingness to investigate their use as a QC tool.

CONTENT

This Review describes the development of various patient-based quality control techniques from the earliest Average of Normals approach including the Moving Average, Moving Median and Moving Sum of Outliers. Variations such as weighting, transformation and annealing are discussed. Integrating patient-based QC and conventional QC is discussed as the problem of sub-populations.

SUMMARY

Patient-based QC methods will become more widespread as their benefits are more fully understood and middleware becomes available that allows laboratories to implement these techniques with their patient populations.

摘要

背景

基于患者的质量控制技术已被描述五十多年,在血液学领域常规广泛使用已有四十年。然而,由于实际问题,它们尚未在临床化学实验室中广泛应用。但最近,由于中间件的可用性以及对这些流程益处的更深入认识,人们愿意研究将其用作质量控制工具。

内容

本综述描述了从最早的正常均值法发展而来的各种基于患者的质量控制技术,包括移动均值、移动中位数和异常值移动总和。还讨论了加权、变换和退火等变体。作为亚群问题,讨论了整合基于患者的质量控制和传统质量控制。

总结

随着基于患者的质量控制方法的益处得到更充分理解,并且有了使实验室能够针对其患者群体实施这些技术的中间件,基于患者的质量控制方法将变得更加普遍。

相似文献

1
A primer on patient-based quality control techniques.基于患者的质量控制技术入门。
Clin Biochem. 2019 Feb;64:1-5. doi: 10.1016/j.clinbiochem.2018.12.004. Epub 2018 Dec 11.
2
Moving sum of number of positive patient result as a quality control tool.作为一种质量控制工具的阳性患者结果数量移动总和。
Clin Chem Lab Med. 2017 Oct 26;55(11):1709-1714. doi: 10.1515/cclm-2016-0950.
3
Implementation of patient-based real-time quality control.基于患者的实时质量控制的实施。
Crit Rev Clin Lab Sci. 2020 Dec;57(8):532-547. doi: 10.1080/10408363.2020.1765731. Epub 2020 Jun 2.
4
Quality control in hematology.血液学中的质量控制。
Clin Lab Med. 1986 Dec;6(4):675-88.
5
Patient population controls.患者群体对照。
Clin Lab Med. 2013 Mar;33(1):139-46. doi: 10.1016/j.cll.2012.11.002. Epub 2012 Dec 20.
6
Patient-Based Real-Time Quality Control: Review and Recommendations.基于患者的实时质量控制:审查与建议。
Clin Chem. 2019 Aug;65(8):962-971. doi: 10.1373/clinchem.2019.305482. Epub 2019 Jul 1.
7
Design and implementation of quality control plans that integrate moving average and internal quality control: incorporating the best of both worlds.设计和实施整合移动平均值和内部质量控制的质量控制计划:融合两者的最佳实践。
Clin Chem Lab Med. 2019 Aug 27;57(9):1329-1338. doi: 10.1515/cclm-2019-0027.
8
Using Sigma Quality Control to Verify and Monitor Performance in a Multi-Instrument, Multisite Integrated Health Care Network.使用西格玛质量控制来验证和监测多仪器、多站点综合医疗保健网络中的性能。
Clin Lab Med. 2017 Mar;37(1):207-241. doi: 10.1016/j.cll.2016.10.001. Epub 2016 Dec 26.
9
Serial correlation of quality control data--on the use of proper control charts.质量控制数据的序列相关性——关于正确控制图的使用
Scand J Clin Lab Invest. 2004;64(3):195-203. doi: 10.1080/00365510410005442.
10
Implementation and application of moving average as continuous analytical quality control instrument demonstrated for 24 routine chemistry assays.移动平均法作为连续分析质量控制工具的实施与应用在24项常规化学检测中得到了验证。
Clin Chem Lab Med. 2017 Jul 26;55(8):1142-1151. doi: 10.1515/cclm-2016-0696.

引用本文的文献

1
Spreadsheet for Patient-Based Quality Control Analysis and Evaluation (SPAE).基于患者的质量控制分析与评估电子表格(SPAE)
EJIFCC. 2025 Feb 28;36(1):26-36. eCollection 2025 Mar.
2
Behind the scenes of EQA - characteristics, capabilities, benefits and assets of external quality assessment (EQA).EQA幕后故事——外部质量评估(EQA)的特点、能力、益处及优势
Clin Chem Lab Med. 2025 Jan 6;63(5):844-858. doi: 10.1515/cclm-2024-1289. Print 2025 Apr 28.
3
Next-Generation Patient-Based Real-Time Quality Control Models.基于下一代患者的实时质量控制模型。
Ann Lab Med. 2024 Sep 1;44(5):385-391. doi: 10.3343/alm.2024.0053. Epub 2024 Jun 5.
4
Integrating moving average control procedures into the risk-based quality control plan in small-volume medical laboratories.将移动平均控制程序整合到小体积医学实验室基于风险的质量控制计划中。
Biochem Med (Zagreb). 2022 Jun 15;32(2):020711. doi: 10.11613/BM.2022.020711.
5
An Objective Approach to Deriving the Clinical Performance of Autoverification Limits.客观方法推导自动验证限的临床性能。
Ann Lab Med. 2022 Sep 1;42(5):597-601. doi: 10.3343/alm.2022.42.5.597.
6
A study of the moving rate of positive results for use in a patient-based real-time quality control program on a procalcitonin point-of-care testing analyzer.一项关于降钙素原即时检测分析仪基于患者实时质量控制项目中阳性结果移动率的研究。
J Clin Lab Anal. 2022 Apr;36(4):e24320. doi: 10.1002/jcla.24320. Epub 2022 Mar 7.
7
Moving average procedures as an additional tool for real-time analytical quality control: challenges and opportunities of implementation in small-volume medical laboratories.移动平均法作为实时分析质量控制的附加工具:在小体积医学实验室中的实施挑战和机遇。
Biochem Med (Zagreb). 2022 Feb 15;32(1):010705. doi: 10.11613/BM.2022.010705. Epub 2021 Dec 15.
8
Patient-based quality control for glucometers: using the moving sum of positive patient results and moving average.基于患者的血糖仪质量控制:使用正患者结果的移动总和和移动平均值。
Biochem Med (Zagreb). 2020 Jun 15;30(2):020709. doi: 10.11613/BM.2020.020709.
9
Optimization and validation of patient-based real-time quality control procedure using moving average and average of normals with multi-rules for TT3, TT4, FT3, FT3, and TSH on three analyzers.使用移动平均值和正常平均值以及多规则对 TT3、TT4、FT3、FT4 和 TSH 在三台分析仪上进行基于患者的实时质量控制程序的优化和验证。
J Clin Lab Anal. 2020 Aug;34(8):e23314. doi: 10.1002/jcla.23314. Epub 2020 May 3.
10
Measurement Uncertainty Impacts Diagnosis of Diabetes Mellitus: Reliable Minimal Difference of Plasma Glucose Results.测量不确定度对糖尿病诊断的影响:血浆葡萄糖结果的可靠最小差异
Diabetes Ther. 2020 Jan;11(1):293-303. doi: 10.1007/s13300-019-00740-w. Epub 2019 Dec 16.